跳至主要内容
临床试验/NCT05743049
NCT05743049招募中不适用

Protocol to Permit Collection of Circulating Biomarkers in Pancreatic Cancer

Abramson Cancer Center at Penn Medicine1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年2月27日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
1
主要终点
To create a comprehensive system to collect, catalogue and store blood specimens from subjects with pancreatic cancer for future research use.

研究概览

简要总结

This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The subject must have a known or presumed diagnosis of pancreatic adenocarcinoma
  • The subject must be a patient of the University of Pennsylvania
  • The subject must be able to provide informed consent
  • The subject must be 18 years of age or older

排除标准

  • . Subjects who have any clinically significant psychiatric, social, or medical condition that, in the opinion of the investigator, could increase the patient's risk, interfere with protocol adherence, or affect the patient's ability to give informed consent are ineligible to participate in the study.

结局指标

主要结局

To create a comprehensive system to collect, catalogue and store blood specimens from subjects with pancreatic cancer for future research use.

时间窗: Through study completion, an average of 1 year

次要结局

  • To create a computerized clinical data set from subjects with pancreatic cancer that contains information related to the subject's general health, disease status, treatments, and response.(Through study completion, an average of 1 year)
  • To integrate the data and specimens to permit the most informative clinical-biologic research platform.(Through study completion, an average of 1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验